Details of the federal initiative to end the epidemic

This finding from a recent study does not necessarily mean that such laws directly inhibit the use of PrEP.

This bureaucratic requirement may frustrate access to PrEP in the U.S. region where the HIV epidemic is the most severe.

A handful of such cases have been reported since Truvada was approved as pre-exposure prophylaxis in 2012.

Total payments for the HIV prevention pill exceeded $2 billion in 2018.

Rates also declined among Black and Latino men, though COVID-19 disruptions threaten the trend.

This finding calls into question research that has projected that frequent testing among men on PrEP could drive down STI rates.

The D-peptide HIV entry inhibitor CPT31 is being developed with hopes it could be injected quarterly for both treatment and prevention.

A digital dashboard displays six gauges in the nation’s effort to lower HIV rates by 90% by 2030.

At My House Clinic, which also offers hep C and COVID-19 services, PRIDE stands for “Promotes Respect Inclusion & Dignity for Everyone.”